David Crowe

David Crowe is an experienced oncology sales professional with a strong background in hematology and oncology account management. Currently serving as an Account Manager for Hematology at BeiGene since November 2019, prior positions include Oncology Account Manager at Verastem Oncology and Area Manager at TESARO, Inc. David's expertise encompasses successful product launches, including Xtandi for metastatic castration-resistant prostate cancer and Kyprolis for relapsed/refractory multiple myeloma, covering territories across Wisconsin, Upper Peninsula of Michigan, and Eastern Iowa. With a solid foundation in strategic account management, David's experience spans over two decades and includes roles at notable companies such as Sanofi Oncology, Onyx Pharmaceuticals, and Bristol-Myers Squibb, focusing on building key customer relationships and achieving sales objectives. David earned a BA in Public Relations/Marketing from the University of Wisconsin-Whitewater.